Astellas Pharma Inc.:企業のM&A・事業提携・投資動向

◆英語タイトル:Astellas Pharma Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C2038
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:132
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Astellas Pharma Inc. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s Astellas Pharma Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Astellas Pharma Inc. since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes Astellas Pharma Inc.’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Astellas Pharma Inc.. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on Astellas Pharma Inc.’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Astellas Pharma Inc. and its subsidiaries since 2007.
- Information about key financial and legal advisors for Astellas Pharma Inc.’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Astellas Pharma Inc.’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 5
LIST OF TABLES 6
LIST OF FIGURES 6
TARGETS AND PARTNERS 7
MERGERS & ACQUISITIONS 14
Mergers and Acquisitions – Overview 14
Mergers and Acquisitions – Deal reports 15
CORPORATE VENTURING 22
Corporate Venturing – Overview 22
Corporate Venturing – Deal reports 23
PARTNERSHIP 27
Partnership – Overview 27
Partnership – Deal reports 28
DIVESTMENTS 117
Divestments – Overview 117
Divestments – Deal reports 118
APPENDIX 122
Contact Us 122
About MarketLine Financial Deals Database 122
Deal Definition and Methodology 124
About MarketLine 131

List of Tables
Table 1: Astellas Pharma Inc M&A volume and value trend (2014-YTD2018)
Table 2: Astellas Pharma Inc M&A activity by geography (2014-YTD2018)
Table 3: Astellas Pharma Inc corporate venturing volume and value trend (2014-YTD2018)
Table 4: Astellas Pharma Inc corporate venturing by geography (2014-YTD2018)
Table 5: Astellas Pharma Inc partnership volume and value trend (2014-YTD2018)
Table 6: Astellas Pharma Inc partnership trend by key deal type (2014-YTD2018)
Table 7: Astellas Pharma Inc divestments volume and value trend (2014-YTD2018)

List of Figures
Figure 1: Astellas Pharma Inc M&A volume and value trend (2014-YTD2018)
Figure 2: Astellas Pharma Inc M&A activity by geography (2014-YTD2018)
Figure 3: Astellas Pharma Inc corporate venturing volume and value trend (2014-YTD2018)
Figure 4: Astellas Pharma Inc corporate venturing by geography (2014-YTD2018)
Figure 5: Astellas Pharma Inc partnership volume and value trend (2014-YTD2018)
Figure 6: Astellas Pharma Inc partnership trend by key deal type (2014-YTD2018)
Figure 7: Astellas Pharma Inc divestments volume and value trend (2014-YTD2018)

★海外企業調査レポート[Astellas Pharma Inc.:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • ORChem Co., Ltd.:企業のM&A・事業提携・投資動向
    ORChem Co., Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's ORChem Co., Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • King Country Energy Ltd:企業の戦略的SWOT分析
    King Country Energy Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Trimedyne Inc:企業の戦略的SWOT分析
    Trimedyne Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Revance Therapeutics Inc (RVNC):製薬・医療:M&Aディール及び事業提携情報
    Summary Revance Therapeutics Inc (Revance Therapeutics) develops, manufactures and commercializes novel botulinum toxin products. The company’s product candidate includes RT002, an injectable formulation of botulinum toxin type for the treatment of glabellar lines, cervical dystonia, and plantar fas …
  • Performance Food Group:企業の戦略・SWOT・財務分析
    Performance Food Group - Strategy, SWOT and Corporate Finance Report Summary Performance Food Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Dairy Farmers of America Inc:戦略・SWOT・企業財務分析
    Dairy Farmers of America Inc - Strategy, SWOT and Corporate Finance Report Summary Dairy Farmers of America Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Cisco Systems, Inc (CSCO)-石油・ガス分野:企業M&A・提携分析
    Summary Cisco Systems, Inc (Cisco) is a technology services provider, which designs, manufactures and sells Internet protocol (IP)-based networking systems and other products. The company’s products include blade switches, analytics and automation software, application networking services, interface …
  • Student Transportation Inc.
    Student Transportation Inc. - Strategy, SWOT and Corporate Finance Report Summary Student Transportation Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • GBST Holdings Limited (GBT):企業の財務・戦略的SWOT分析
    GBST Holdings Limited (GBT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • UPL Ltd (UPL):企業の財務・戦略的SWOT分析
    UPL Ltd (UPL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Vallourec SA:戦略・SWOT・企業財務分析
    Vallourec SA - Strategy, SWOT and Corporate Finance Report Summary Vallourec SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Fred’s, Inc.:戦略・SWOT・企業財務分析
    Fred's, Inc. - Strategy, SWOT and Corporate Finance Report Summary Fred's, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • China Petrochemical Corp:企業のM&A・事業提携・投資動向
    China Petrochemical Corp - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's China Petrochemical Corp Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • Sujana Universal Industries Ltd. (SUJANAUNI):企業の財務・戦略的SWOT分析
    Sujana Universal Industries Ltd. (SUJANAUNI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stren …
  • Sanderson Farms Inc:企業の戦略・SWOT・財務分析
    Sanderson Farms Inc - Strategy, SWOT and Corporate Finance Report Summary Sanderson Farms Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Union Electrica SA:企業の戦略的SWOT分析
    Union Electrica SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Vattenfall AB-エネルギー分野:企業M&A・提携分析
    Summary Vattenfall AB (Vattenfall) is a state-owned energy company that generates, distributes and sells electricity and heat. It is one of the leading generators of electricity and heat in Europe. The company also conducts the sale of gas and energy trading. Vattenfall generates power through vario …
  • Affymetrix, Inc.-医療機器分野:企業M&A・提携分析
    Summary Affymetrix, Inc. (Affymetrix) provides life science, and molecular diagnostic products for analysis of biological systems at gene, protein and cellular level. It offers products for two major applications, namely, genotyping and gene expression. Affymetrix offers three families of instrument …
  • MVV Energie AG:企業の戦略・SWOT・財務情報
    MVV Energie AG - Strategy, SWOT and Corporate Finance Report Summary MVV Energie AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Taiwan Liposome Co Ltd (4152):企業の財務・戦略的SWOT分析
    Summary Taiwan Liposome Co Ltd (TLC) is a clinical-stage pharmaceutical company, which develops and commercializes novel nanomedicines based on drug delivery technology platform. The company’s pipeline products include TLC599, TLC590, TLC399 and TLC178. Its TLC 178 is used for the treatment of adult …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆